BioSpace News Archive

Policy

FTC Lawsuit Holds Up IQVIA’s Advertising Acquisition of Propel Media

The Federal Trade Commission’s increased scrutiny of mergers has now hit IQVIA, whose proposed acquisition of Propel Media has been challenged by the watchdog agency.

July 26, 2023
·
2 min read
·
Tristan Manalac
Business

GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot

While GlaxoSmithKline is anticipating a slower uptake of respiratory syncytial virus vaccine Arexvy, CEO Emma Walmsley said Wednesday the company is pinning much of its growth on the vaccine’s performance.

July 26, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Merck, Moderna Launch Pivotal Cancer Vaccine Trial for High-Risk Melanoma

The Phase III trial, which will test the companies’ mRNA-based personalized cancer vaccine and Merck’s blockbuster Keytruda checkpoint inhibitor, is slated for completion by the fall of 2029.

July 26, 2023
·
2 min read
·
Kate Goodwin
Business

FibroGen CEO Resigns Amid Clinical Losing Streak, Layoffs

Following several clinical failures for its candidates Roxadustat and pamrevlumab, FibroGen CEO Enrique Conterno is stepping down for “personal reasons,” the company announced Tuesday.

July 26, 2023
·
2 min read
·
Tristan Manalac
Job Trends

The 9 US States with the Best Job Markets Hiring Now

In a recent study of the U.S. states with the best and worst job markets, nine came out on top. Read on for details about the life sciences industry and jobs available in each state.

July 26, 2023
·
4 min read
·
Rosemary Scott
Policy

UK Probes Weight Loss, Diabetes Drugs for Suicidal Ideation and Self-Harm Risk

On the heels of a European Union investigation, the UK’s health agency is reviewing safety data for GLP-1 receptor agonists after reports of self-harm and suicidal thoughts.

July 26, 2023
·
2 min read
·
Connor Lynch
Biotech Bay

Noctrix Health announces publication of landmark results from randomized clinical trial and long-term extension study of its revolutionary Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS) in Sleep

Noctrix Health, Inc. announced a double feature in the renowned peer-reviewed journal, Sleep, showcasing the outcomes of two major clinical trials that assessed TOMAC therapy for the treatment of RLS.

July 26, 2023
·
5 min read
Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Edesa Biotech, Inc. announced today that the company will participate in a Fireside Chat and host one-on-one meetings at the Canaccord Genuity 43rd Annual Growth Conference being held in Boston from August 7-10, 2023.

July 26, 2023
·
3 min read
Biotech Bay

Octave Bioscience Closes $30M Extension to Series B Funding

Octave Bioscience today announced the closing of a $30M extension to its Series B funding round.

July 26, 2023
·
4 min read
Biotech Beach

Immunis Releases Article Highlighting the Potential of Cell Secretome Therapies in Addressing Immune and Age-Related Diseases

Immunis, Inc. releases an informative article about the incredible potential of secretomes.

July 26, 2023
·
14 min read